The Big News From Wednesday

Did you see what happened on Wednesday? Recursion Pharmaceuticals (RXRX), a biotech company that uses AI to discover new drugs, just got a $50 million investment from Nvidia (NVDA), the leading maker of AI chips. [Stansberry Digest] The Big News From Wednesday --------------------------------------------------------------- Did you see what happened on Wednesday? Recursion Pharmaceuticals (RXRX), a biotech company that uses AI to discover new drugs, just got a $50 million investment from Nvidia (NVDA), the leading maker of AI chips. And the market went wild. RXRX soared 100% at the open and closed with a stunning 78% gain. Which led us to ask ourselves... [Is this another sign of a growing AI mania, or is this the beginning of one of the most important technology stories of our time?]( After all, it isn't just tech stocks benefiting from a surging interest in AI anymore. Now, the biotech industry can be an AI investment. And you can be sure that stocks in more and more industries will soon be associating themselves with AI, too. So, how do you separate the companies who are actually using AI to grow their business from the dozens of companies trying to take advantage of this trend? And furthermore, is this technology something Americans should even be investing in? [Fortunately, on July 19, two Wall Street legends have agreed to join forces for the first time ever to answer all your most pressing questions about AI.]( They'll discuss exactly how this AI mania is taking shape... which AI stocks to avoid... and help you find the real opportunities to position yourself to grow your wealth – 100% free. You'll hear from Marc Chaikin, who predicted the bank run of 2023 five months in advance, the market crashes of 2020 and 2022, and built the system that pointed to the top ten stocks of 2022. You'll also hear from Dr. David "Doc" Eifrig, a former Wall Street insider who traded through Black Monday in 1987... the savings and loan crisis that followed that... the Asian debt crisis in 1997... the Dot-Com Bubble in 2001... the Great Recession in 2009... the Covid crash... and of course, the 2022 crash just last year. [Please, I encourage you to tune in and reserve your spot.]( Now, Marc and Doc have very different investing philosophies... So this is your rare opportunity to learn from two of the smartest investors in the world... and hear contrasting perspectives about AI's financial impact. Whether you've been following the advancements in AI closely, or if you simply want to get up to speed on what's happening, I encourage you to RSVP today. No matter your interest level, we can promise you'll walk away from Marc and Doc's debate on July 19 understanding the potential of AI in a way you simply never have before. In short: If you've been feeling lost in the midst of all the talk about AI, this is a must-see event. [Click here for the full details and to RSVP (free).]( Regards, Brett Aitken Publisher, Stansberry Research Published by Stansberry Research. You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer wish to receive special offers from Stansberry Digest, [click here](. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized investment advice. © 2023 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 [www.stansberryresearch.com](.